BIO PE Ratio 2026
Bio-Rad Laboratories Inc Price to Earnings Analysis
Current P/E Ratio
52.47
Stock Price
$312.48
EPS (TTM)
$6.01
Valuation
Overvalued
PE Ratio Breakdown
Trailing P/E (TTM)
52.47
Based on last 12 months earnings
Health Care Industry Avg
20.00
BIO is 162% above industry
What Does BIO P/E Ratio Mean?
Current Valuation
At a P/E ratio of 52.47, investors are paying $52.47 for every $1 of BIO's annual earnings. This high P/E suggests investors expect strong future earnings growth or that the stock is trading at a premium.
Industry Comparison
Compared to the Health Care industry average P/E of 20, BIO is trading at a premium. This could be justified by superior growth, profitability, or competitive position.
PE Ratio Calculator
How P/E ratio changes with different stock prices:
At $249.98
P/E: 41.59
20% lower
At $281.23
P/E: 46.79
10% lower
At $343.73
P/E: 57.19
10% higher
At $374.98
P/E: 62.39
20% higher
Get Complete BIO Valuation Analysis
DCF model, comparable companies, and AI-powered insights
Frequently Asked Questions
What is BIO PE ratio?
BIO (Bio-Rad Laboratories Inc) has a price-to-earnings (P/E) ratio of 52.47. This means investors are paying $52.47 for every $1 of BIO's annual earnings. The P/E ratio is a key valuation metric used to assess whether a stock is overvalued or undervalued relative to its earnings.
What is a good PE ratio?
A "good" P/E ratio depends on the industry and growth prospects. Generally, a P/E ratio between 15-25 is considered reasonable for mature companies. Growth stocks often trade at higher P/E ratios (30-50+) due to expected future earnings growth. Value stocks typically have lower P/E ratios (below 15). Compare BIO's P/E of 52.47 to its industry average and historical range.
Is BIO overvalued based on PE ratio?
BIO's P/E ratio of 52.47 is above the Health Care industry average of approximately 20. This suggests the stock may be trading at a premium, though high P/E ratios can be justified by strong growth prospects.
What is the difference between forward and trailing PE ratio?
The trailing P/E ratio uses earnings from the past 12 months (historical data), while the forward P/E ratio uses projected earnings for the next 12 months (future estimates). BIO's trailing P/E is 52.47. Forward P/E is often more useful for growth companies as it reflects expected future performance.
How do you calculate PE ratio?
P/E ratio is calculated by dividing the stock price by earnings per share (EPS). Formula: P/E = Stock Price / EPS. For BIO, with a current price of $312.48 and EPS of $6.01, the P/E ratio is 51.99. A higher P/E means investors pay more per dollar of earnings.
What is PEG ratio and how does it relate to PE?
The PEG ratio adjusts P/E for growth. PEG = P/E / Earnings Growth Rate. A PEG below 1.0 typically indicates good value. Calculate BIO's PEG ratio when earnings growth data is available.